WASHINGTON, D.C.-While continuing to tout the success of using private plans to provide prescription drug benefits to millions of seniors, the Centers for Medicare and Medicaid Services (CMS) also is waving a big stick. The agency announced in June that it has taken more than 1,000 compliance actions to resolve beneficiary complaints and ensure adequate service, part of its campaign to demonstrate that CMS can police this huge new program.
WASHINGTON, D.C.-While continuing to tout the success of using private plans to provide prescription drug benefits to millions of seniors, the Centers for Medicare and Medicaid Services (CMS) also is waving a big stick. The agency announced in June that it has taken more than 1,000 compliance actions to resolve beneficiary complaints and ensure adequate service, part of its campaign to demonstrate that CMS can police this huge new program.
Most CMS enforcement actions request prescription drug plans (PDPs) and Medicare Advantage drug plans (MA-PDs) to provide more accurate information and improve service for patients. In the program's first six months, the agency issued:
CMS also took action in 75 situations to temporarily restrict plan marketing activities. Such cases most often arose from a plan posting incorrect information about drug prices and formularies or imposing inappropriate utilization curbs on a covered drug.
Overall, CMS said its complaint rate for MA-PDs averaged 1.6 per 1,000 beneficiaries-compared with 2.5 per 1,000 beneficiaries for stand-alone PDPs. Most complaints have been about enrollment or disenrollment problems, difficulties obtaining needed drugs and unhappiness about the cost of drugs or incorrect co-pays at the pharmacy counter.
At the same time, MA plans have been the target of more serious CMS enforcement action in two cases. The agency has imposed a corrective action plan on one MA-PD that had problems assuring access to medicines for new enrollees during the transitional coverage period. CMS is reportedly looking to terminate America's Health Choice of Florida because of continued marketing violations.
FDA Approves First At-Home Cervical Cancer Screening Device
May 15th 2025Self-collected samples to test for cervical cancer are a step in the right direction when it comes to addressing healthcare barriers, according to Rahma S. Mkuu, Ph.D., M.P.H., assistant professor in the Department of Health Outcomes & Biomedical Informatics at the University of Florida College of Medicine.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
The First Financial Toxicity Tumor Board Reports Success in Individual Patient Savings
May 14th 2025Financial toxicity can affect patient outcomes and quality of life. For example, a patient may forgo treatment or medications to save money, or they may incur high medical debt or go into bankruptcy to pay for medical care.
Read More